Zhang Y, Xu M, Yuan J, Hu Z, Jiang J, Sun Y, Huang J, Wang Y, Wang B, Shen J, Long M, Fan Y, Montone KT, Tanyi J, Kim SH, Tavana O, Vonderheide RH, Chan HM, Domchek S, Zhang L, Hu X. Repression of PRMT activities sensitize human homologous recombination-proficient ovarian and breast cancer cells
to PARP inhibitor treatment , Elife: 2026
Tung NM, Robson ME, Li T, Nanda R, Shah PD, Khoury K, Kimmick G, Santa-Maria C, Brufsky A, DeMeo M, Vieira JP, Carey LA, Wulf G, Domchek S, Krop IE, Wolff AC, Winer EP, Garber JE; Translational Breast Cancer Research Consortium (TBCRC). TBCRC 048 (Olaparib Expanded) Expansion Cohorts: Phase II Study of Olaparib Monotherapy for Patients With Metastatic Breast Cancer With Germline Mutations in Germline Mutations in PALB2
or Somatic Mutations in BRCA1 or BRCA2. , J. CLin Oncol : 2026
Domchek SM.
Therapeutic Considerations in Early-Stage, Estrogen Receptor-Positive, BRCA-Associated Breast Cancer. , J Clin Oncol.: 2026
Smyczynska U, Rycerz A, Kozlowska K, Symecko H, Brower J, Domchek SM, Elias K, Konstantinopoulos P, Apostolidou S, Menon U, Fendler W, Chowdhury D. Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations.
, Biomark Res., 14(1): 2026,9
Darrah KE, Hemker SL, Rawal Y, Goff NJ, Parker P, Ganesan G, Stratton CM, Oppenheimer K, Roberts E, Glick E, Banks N, Kumar A, Casadei S, Snyder MW, Nathanson K, Domchek SM, Starita LM, Olsen SK, Sung P, Kitzman JO, Bernstein KA. High-throughput mapping of 6,888 RAD51D variants identifies distinct
biochemical functions needed for homologous recombination and olaparib response. , bioRxiv.: 2026
Hu X, Huang J, Yuan J, Sun Y, Wang Y, Hu Z, Jiang J, Wang Z, Wang B, Long M, Maxwell KN, Fan Y, Tanyi JL, Montone KT, Li H, Kim SH, Nathanson KL, Rebbeck TR, Domchek SM, Vonderheide RH, Zhang L., Immune gene diversity and STING1 variants in shaping cancer immunity across different genetic ancestry populations. , Cell Rep., 45(2): 2026
Hickey M, Tejada-Berges T, Domchek SM, Krejany EO, Brand A, Li P, Braat S, Kingsberg S. Sexual Function, Activity and Distress 24 Months After Surgical Menopause: What Happens After Menopause (WHAM)-A Prospective Controlled Study , BJOG : 2026
O'Brien KM, Keil AP, Taylor JA, Weinberg CR, Polley EC, Yadav S, Boddicker NJ, Hu C, Ambrosone CB, Anton-Culver H, Auer PL, Bodelon C, Brantley K, Burnside ES, Chen F, Domchek SM, Eliassen AH, Haiman CA, Hodge JM, Kraft P, Lacey JV, Lindstroem S, Martinez ME, Nathanson KL, Neuhausen SL, Olson JE, Palmer JR, Patel AV, Penney KL, Ruddy KJ, Scott CG, Teras LR, Trentham-Dietz A, Vachon CM, Weitzel JN, Yao S, Zirpoli G, Couch FJ, Sandler DP. Pathogenic Variants, Family History, and Cumulative Risk of Breast
Cancer in US Women. , JAMA Oncol., 11(12): 2025,458-1469
Mastaglio E, Egleston B, Lee KT, Fetzer D, Brown S, Domchek SM, Fleisher L, Wen KY, Wagner L, Roberts JS, Cacioppo C, Christiansen J, Howe S, Wood EM, Weinberg M, Karpink K, Selmani E, Feng J, John S, Schweickert K, McLeod B, Bradbury AR. A Randomized Hybrid Type I Effectiveness-Implementation
Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (eREACH2):study protocol. , medRxiv: 2025
O'Brien KM, Keil AP, Taylor JA, Weinberg CR, Polley EC, Yadav S, Boddicker NJ, Hu C, Ambrosone CB, Anton-Culver H, Auer PL, Bodelon C, Brantley K, Burnside ES, Chen F, Domchek SM, Eliassen AH, Haiman CA, Hodge JM, Kraft P, Lacey JV, Lindstroem S, Martinez ME, Nathanson KL, Neuhausen SL, Olson JE, Palmer JR, Patel AV, Penney KL, Ruddy KJ, Scott CG, Teras LR, Trentham-Dietz A, Vachon CM, Weitzel JN, Yao S, Zirpoli G, Couch FJ, Sandler DP. Pathogenic Variants, Family History, and Cumulative Risk of Breast Cancer in US Women , JAMA Oncol: 2025
